Detalhe da pesquisa
1.
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Br J Dermatol
; 190(2): 216-225, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877514
2.
Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1.
J Invest Dermatol
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368929
3.
cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.
J Invest Dermatol
; 143(11): 2226-2232.e1, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149083